ZSAN logo

Zosano Pharma (ZSAN) Cash From Investing

Annual CFI

-$5.42 M
+$3.06 M+36.10%

December 31, 2021

Summary

Performance

1-Year Change

+36.1%

3-Year Change

+71.77%

5-Year Change

-341.61%

15-Year Change

-341.61%

ZSAN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$30.27 M
ZSAN annual cash flow from investing activities is currently -117.91% below its historical high of $30.27 million

3-Year Low

-$5.42 M
ZSAN annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
ZSAN previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
ZSAN next annual earnings announcement has not yet been scheduled

OtherZSANcash flowmetrics:

Annual CFF

$8.79 M
ZSAN annual cash flow from financing activities is $8.79 million

Annual CFO

-$27.59 M
ZSAN annual cash flow from operations is -$27.59 million

Annual FCF

-$33.01 M
ZSAN annual free cash flow is -$33.01 million

Annual CAPEX

$5.42 M
ZSAN annual capital expenditures is $5.42 million

Quarterly CFI

-$65.00 K
+$343.00 K+84.07%

March 31, 2022

Summary

Performance

3-Month Change

+84.07%

1-Year Change

+97.99%

3-Year Change

-101.3%

5-Year Change

+15.58%

ZSAN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.92 M
ZSAN quarterly cash flow from investing activities is currently -100.73% below its historical high of $8.92 million

3-Year Low

-$408.00 K

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
ZSAN previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
ZSAN next earnings announcement has not yet been scheduled

OtherZSANcash flowmetrics:

Quarterly CFF

$11.09 M
ZSAN quarterly cash flow from financing activities is $11.09 million

Quarterly CFO

-$8.54 M
ZSAN quarterly cash flow from operations is -$8.54 million

Quarterly FCF

-$8.61 M
ZSAN quarterly free cash flow is -$8.61 million

Quarterly CAPEX

$65.00 K
ZSAN quarterly capital expenditures is $65.00 thousand

TTM CFI

-$2.25 M
+$3.17 M+58.47%

March 31, 2022

Summary

Performance

3-Month Change

+58.47%

1-Year Change

+78.22%

3-Year Change

-204.07%

5-Year Change

-204.07%

ZSAN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$34.45 M
ZSAN TTM cash flow from investing activities is currently -106.54% below its historical high of $34.45 million

3-Year Low

-$5.42 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
ZSAN previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
ZSAN next earnings announcement has not yet been scheduled

OtherZSANcash flowmetrics:

TTM CFF

$17.57 M
ZSAN TTM cash flow from financing activities is $17.57 million

TTM CFO

-$28.67 M
ZSAN TTM cash flow from operations is -$28.67 million

TTM FCF

-$30.92 M
ZSAN TTM free cash flow is -$30.92 million

TTM CAPEX

$2.25 M
ZSAN TTM capital expenditures is $2.25 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ZSAN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.1%+98.0%+78.2%
3 y3 years+71.8%-101.3%-204.1%
5 y5 years-341.6%+15.6%-204.1%

ZSAN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+527.7%at high+140.8%
5 y5-year-350.6%+56.5%at high+5012.3%-204.1%+359.1%
alltimeall time-117.9%+470.6%-100.7%>+9999.0%-106.5%+1817.7%

Zosano Pharma Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2022
-
-$65.00 K(-84.1%)
-$2.25 M(-58.5%)
Dec 2021
-$5.42 M(-36.1%)
-$408.00 K(-31.1%)
-$5.42 M(-6.4%)
Sep 2021
-
-$592.00 K(-50.1%)
-$5.79 M(-29.4%)
Jun 2021
-
-$1.19 M(-63.3%)
-$8.20 M(-20.7%)
Mar 2021
-
-$3.24 M(+317.0%)
-$10.34 M(+21.8%)
Dec 2020
-$8.49 M(-492.2%)
-$776.00 K(-74.2%)
-$8.49 M(-0.5%)
Sep 2020
-
-$3.00 M(-9.6%)
-$8.53 M(+26.3%)
Jun 2020
-
-$3.32 M(+140.1%)
-$6.75 M(+60.7%)
Mar 2020
-
-$1.38 M(+68.6%)
-$4.20 M(-294.3%)
Dec 2019
$2.16 M(-111.3%)
-$821.00 K(-33.0%)
$2.16 M(-59.2%)
Sep 2019
-
-$1.23 M(+58.6%)
$5.30 M(-38.2%)
Jun 2019
-
-$773.00 K(-115.5%)
$8.58 M(-162.3%)
Mar 2019
-
$4.98 M(+115.4%)
-$13.78 M(-28.3%)
Dec 2018
-$19.21 M(+1464.6%)
$2.31 M(+12.7%)
-$19.21 M(+23.9%)
Sep 2018
-
$2.05 M(-108.9%)
-$15.51 M(-9.5%)
Jun 2018
-
-$23.13 M(+5028.6%)
-$17.14 M(+969.6%)
Mar 2018
-
-$451.00 K(-107.5%)
-$1.60 M(+30.5%)
Dec 2017
-$1.23 M
$6.02 M(+1309.6%)
-$1.23 M(-59.4%)
DateAnnualQuarterlyTTM
Sep 2017
-
$427.00 K(-105.6%)
-$3.03 M(-155.4%)
Jun 2017
-
-$7.60 M(+9766.2%)
$5.46 M(-75.1%)
Mar 2017
-
-$77.00 K(-101.8%)
$21.94 M(-27.5%)
Dec 2016
$30.27 M(-197.8%)
$4.22 M(-52.7%)
$30.27 M(-12.1%)
Sep 2016
-
$8.92 M(+0.4%)
$34.45 M(+19.2%)
Jun 2016
-
$8.88 M(+7.6%)
$28.91 M(-227.8%)
Mar 2016
-
$8.25 M(-1.7%)
-$22.63 M(-26.9%)
Dec 2015
-$30.95 M(+2631.3%)
$8.40 M(+148.4%)
-$30.95 M(-21.5%)
Sep 2015
-
$3.38 M(-107.9%)
-$39.44 M(-8.7%)
Jun 2015
-
-$42.66 M(>+9900.0%)
-$43.19 M(+5516.0%)
Mar 2015
-
-$67.00 K(-34.3%)
-$769.00 K(-32.1%)
Dec 2014
-$1.13 M(-199.5%)
-$102.00 K(-71.9%)
-$1.13 M(+9.9%)
Sep 2014
-
-$363.00 K(+53.2%)
-$1.03 M(+54.3%)
Jun 2014
-
-$237.00 K(-45.0%)
-$668.00 K(+55.0%)
Mar 2014
-
-$431.00 K(-166.5%)
-$431.00 K(-166.5%)
Dec 2013
$1.14 M(-42.6%)
-
-
Mar 2013
-
$648.00 K
$648.00 K
Dec 2012
$1.98 M
-
-

FAQ

  • What is Zosano Pharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Zosano Pharma?
  • What is Zosano Pharma annual CFI year-on-year change?
  • What is Zosano Pharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Zosano Pharma?
  • What is Zosano Pharma quarterly CFI year-on-year change?
  • What is Zosano Pharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Zosano Pharma?
  • What is Zosano Pharma TTM CFI year-on-year change?

What is Zosano Pharma annual cash flow from investing activities?

The current annual CFI of ZSAN is -$5.42 M

What is the all time high annual CFI for Zosano Pharma?

Zosano Pharma all-time high annual cash flow from investing activities is $30.27 M

What is Zosano Pharma annual CFI year-on-year change?

Over the past year, ZSAN annual cash flow from investing activities has changed by +$3.06 M (+36.10%)

What is Zosano Pharma quarterly cash flow from investing activities?

The current quarterly CFI of ZSAN is -$65.00 K

What is the all time high quarterly CFI for Zosano Pharma?

Zosano Pharma all-time high quarterly cash flow from investing activities is $8.92 M

What is Zosano Pharma quarterly CFI year-on-year change?

Over the past year, ZSAN quarterly cash flow from investing activities has changed by +$3.17 M (+97.99%)

What is Zosano Pharma TTM cash flow from investing activities?

The current TTM CFI of ZSAN is -$2.25 M

What is the all time high TTM CFI for Zosano Pharma?

Zosano Pharma all-time high TTM cash flow from investing activities is $34.45 M

What is Zosano Pharma TTM CFI year-on-year change?

Over the past year, ZSAN TTM cash flow from investing activities has changed by +$8.09 M (+78.22%)